Clermont-Ferrand - Chu Estaing

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia2 trials
• Chronic lymphocytic leukaemia1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 22 trials

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• French Innovative Leukemia Organisation3 trials

Running trials

• Active, not recruiting

  French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings

  NCT05590702· French Innovative Leukemia Organisation· Source

• Active, not recruiting

  Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission

  NCT04968015· Phase 2· French Innovative Leukemia Organisation· Source

Closed trials

• Completed

  Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm

  NCT04992949· Phase 2· French Innovative Leukemia Organisation· Source